Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01292005 · ClinicalTrials.gov registry record · Early Phase 1
Pentoxifylline Treatment of Acute Pancreatitis
A Early Phase 1 study of Acute Pancreatitis, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT01292005: Completed Early Phase 1 study of Acute Pancreatitis, sponsored by Mayo Clinic.
NCT01292005 is a Early Phase 1 study of Acute Pancreatitis that has completed, run by Mayo Clinic. The registered enrollment target is 28 participants, below the 2,316-participant average among 10 other Acute Pancreatitis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01292005, a Early Phase 1 study of Acute Pancreatitis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effects (good and bad) of giving a drug called pentoxifylline to patients with acute pancreatitis, to see if it can improve blood tests associated with inflammation (tissue damage). Pentoxifylline is approved by the US Food and Drug Administration (FDA) for treatment of circulation problems, but its use in this study is investigational, which means that the FDA has not approved it for the treatment of pancreatitis. However, the FDA has allowed the use of pentoxifylline in this research study.
Primary Outcome
C-reactive protein is produced by the liver. The level of CRP rises when there is inflammation throughout the body. The normal value range for CRP = 1-10 mg/L.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Pentoxifylline
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-07 |
| Phase | Early Phase 1 |
What the finished NCT01292005 record still lists
NCT01292005 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 2,316-participant average among 10 other Acute Pancreatitis trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Acute Pancreatitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01292005 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01292005 about?
NCT01292005 is a clinical study titled "Pentoxifylline Treatment of Acute Pancreatitis". The purpose of this study is to determine the effects (good and bad) of giving a drug called pentoxifylline to patients with acute pancreatitis, to see if it can improve blood tests associated with inflammation (tissue damage). Pentoxifylline is approved by the US Food and Drug Administration (FDA) ...
What is the current status of trial NCT01292005?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2009-04. Estimated completion is 2012-07.
What conditions does trial NCT01292005 study?
This clinical trial studies the following conditions: Acute Pancreatitis.
What interventions are being tested in trial NCT01292005?
The interventions under investigation include: Placebo (DRUG), Pentoxifylline (DRUG).
Who is sponsoring clinical trial NCT01292005?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01292005 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01292005's enrollment target sits among peer trials
28 10th of 10 higher than 1 of 10 other Acute Pancreatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis
RECRUITING
-
iMmune SignAtures and Clinical outComes in AP
RECRUITING
-
Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections
RECRUITING
-
Necrosectomy With Cryotechnology for Accelerated Removal
RECRUITING · NA
-
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RECRUITING
-
Diabetes RElated to Acute Pancreatitis and Its Mechanisms
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia